GWM
AMPE

Geneos Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Geneos Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39
Closed – – 2132
2022
Q3 		$0 Sell
39
-168
-81% -$5.88K ﹤0.01% 2718
2022
Q2 		$9K Hold
207
– – ﹤0.01% 2018
2022
Q1 		$29K Sell
207
-5
-2% -$730 ﹤0.01% 1625
2021
Q4 		$36K Sell
212
-18
-8% -$6.71K ﹤0.01% 1629
2021
Q3 		$111K Hold
230
– – ﹤0.01% 1134
2021
Q2 		$112K Hold
230
– – ﹤0.01% 1125
2021
Q1 		$127K Hold
230
– – ﹤0.01% 1192
2020
Q4 		$114K Sell
230
-115
-33% -$37.7K ﹤0.01% 1087
2020
Q3 		$97K Buy
345
+191
+124% +$47.3K 0.01% 955
2020
Q2 		$28K Sell
154
-43
-22% -$7.15K ﹤0.01% 1483
2020
Q1 		$25K Buy
197
+50
+34% +$9.05K ﹤0.01% 1426
2019
Q4 		$22K Hold
147
– – ﹤0.01% 1646
2019
Q3 		$21K Buy
147
+114
+345% +$15.2K ﹤0.01% 1595
2019
Q2 		$3K Sell
33
-16
-33% -$2.54K ﹤0.01% 2276
2019
Q1 		$8K Hold
49
– – ﹤0.01% 1929
2018
Q4 		$5K Buy
49
+6
+14% +$921 ﹤0.01% 2018
2018
Q3 		$6K Buy
43
+3
+8% +$1.25K ﹤0.01% 2036
2018
Q2 		$26K Hold
40
– – ﹤0.01% 1352
2018
Q1 		$40K Hold
40
– – ﹤0.01% 1105
2017
Q4 		$48K Buy
40
+7
+21% +$3.29K ﹤0.01% 1018
2017
Q3 		$6K Hold
33
– – ﹤0.01% 1735
2017
Q2 		$5K Hold
33
– – ﹤0.01% 1749
2017
Q1 		$7K Hold
33
– – ﹤0.01% 1615
2016
Q4 		$8K Buy
33
+5
+18% +$1.19K ﹤0.01% 1520
2016
Q3 		$6K Sell
28
-33
-54% -$9.25K ﹤0.01% 1540
2016
Q2 		$23K Buy
61
+10
+20% +$10.9K ﹤0.01% 1077
2016
Q1 		$40K Buy
+51
New +$34.3K 0.01% 869

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Geneos Wealth Management's AMPE Position: Q4 2022 in Review

Geneos Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 39 shares.

Geneos Wealth Management first reported a position in AMPE in Q1 2016 and held it in 27 quarters. The position peaked at $127K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Geneos Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 39 Ampio Pharmaceuticals Inc. shares in Q4 2022.
  • Geneos Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2016 and held it in 27 quarters.
  • Geneos Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $127K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.